Evaxion Biotech A/S (ADR)
General ticker "EVAX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.1M (TTM average)
Evaxion Biotech A/S (ADR) follows the US Stock Market performance with the rate: 24.8%.
Estimated limits based on current volatility of 3.3%: low 3.68$, high 3.92$
Factors to consider:
- Total employees count: 35 as of 2020
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.05$, 8.31$]
- 2026-12-31 to 2027-12-31 estimated range: [2.13$, 6.10$]
Short-term EVAX quotes
Long-term EVAX plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $7.53MM |
| Operating Expenses | $16.76MM |
| Operating Income | $-9.23MM |
| Non-Operating Income | $0.62MM |
| Interest Expense | $0.88MM |
| R&D Expense | $9.97MM |
| Income(Loss) | $-8.62MM |
| Taxes | $-0.91MM |
| Net Income(Loss)* | $-7.68MM |
| Stockholders Equity | $17.04MM |
| Assets | $28.41MM |
| Operating Cash Flow | $-6.65MM |
| Capital expenditure | $0.01MM |
| Investing Cash Flow | $-0.01MM |
| Financing Cash Flow | $22.48MM |
| Earnings Per Share** | $-1.20 |
| Ordinary share to ADR | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.